Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output
Sophie Dupuis-Girod, MD, PhD, Isabelle Ginon, MD, Jean-Christophe Saurin, MD, PhD, Denis Marion, MD, Elsa Guillot, MD, Evelyne Decullier, PhD, Adeline Roux, MsC, Marie-France Carette, MD, PhD, Brigitte Gilbert-Dussardier, MD, PhD, Pierre-Yves Hatron, MD, PhD, Pascal Lacombe, MD, PhD, Bernard Lorcerie, MD, PhD, Sophie Rivière, MD, Romain Corre, MD, Sophie Giraud, MD, PhD, Sabine Bailly, PhD, Gilles Paintaud, MD, PhD, David Ternant, MD, Pierre-Jean Valette, MD, PhD, Henri Plauchu, MD, PhD, Frédéric Faure, MD, PhD
JAMA. 2012;307(9):948-955.
Published online March 7, 2012
Select Pricing Criteria: